N-(2-溴-4-异丙基苯基)-乙酰胺 | 68748-07-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-(2-溴-4-异丙基苯基)-乙酰胺
• 英文名称: N-(2-bromo-4-isopropylphenyl)acetamide
• 英文别名: N-(2-bromo-4-propan-2-ylphenyl)acetamide
• CAS: 68748-07-2
• 化学式: C₁₁H₁₄BrNO
• 分子量: 256.142
• InChiKey: UIBZDELTWFHAPK-UHFFFAOYSA-N

物化性质

• 熔点：
  129 °C
• 沸点：
  366.4±35.0 °C(Predicted)
• 密度：
  1.356±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2924299090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Acetamido-3-bromocumene
Synonyms: N-(2-Bromo-4-isopropylphenyl)acetamide

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Acetamido-3-bromocumene
CAS number: 68748-07-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H14BrNO
Molecular weight: 256.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-(2-溴-4-异丙基苯基)-乙酰胺 在 potassium hydroxide 作用下， 以 水 为溶剂， 反应 1.0h， 以5.94 g的产率得到2-溴-4-异丙基苯胺
  参考文献：
  名称：

  铜催化的对映选择性共轭加成的α，β-不饱和醛与各种有机金属试剂

  摘要：

  致力于纪念Jean F. Normant教授（1936–2016） 抽象的 β取代的醛构成自然界中非常重要的一类化合物。该基序的合成可以通过在烯醛上形成C–C键来实现。为此，我们在本文中报道了以（R）-H 8 BINAP，（R）-TolBINAP和（R）-SEGPHOS为手性的各种有机金属试剂向α，β-不饱和醛的对映选择性铜催化共轭加成反应的发展。配体。成功开发了三套条件，并使用了几种Enals。反应性以及区域和对映体选择性强烈取决于反应条件和底物。用锌试剂R 2获得良好至优异的区域和对映选择性，锌和铝试剂R 3铝 然而，格氏试剂的不对称共轭添加仅提供中等至良好的区域选择性和对映选择性。 β取代的醛构成自然界中非常重要的一类化合物。该基序的合成可以通过在烯醛上形成C–C键来实现。为此，我们在本文中报道了以（R）-H 8 BINAP，（R）-TolBINAP和（R）-SEGPHOS为手性的各

  DOI：

  10.1055/s-0035-1562487
• 作为产物：
  描述：

  2-溴-4-异丙基苯胺 在 乙酸酐 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 N-(2-溴-4-异丙基苯基)-乙酰胺
  参考文献：
  名称：

  Sulfonamides having antiangiogenic and anticancer activity

  摘要：

  描述了具有蛋氨酸氨基肽酶-2抑制剂（MetAP2）的化合物。还描述了包括这些化合物的药物组合物、使用这些化合物的治疗方法、抑制血管生成的方法以及治疗癌症的方法。

  公开号：

  US20040068012A1

文献信息

• Substituted 11-oxo-11H-pyrido[2,1-b]quinazolines and method of
  申请人：Hoffmann-La Roche Inc.

  公开号：US04348396A1

  公开（公告）日：1982-09-07

  Pyrido[2,1-b]quinazolines of the formulas ##STR1## wherein R.sub.1, R.sub.1 ', R.sub.2, R.sub.2 ', R.sub.3, R.sub.3 ', R.sub.4 and R.sub.10 are as hereinafter set forth, and processes for the preparation thereof, are described. The compounds of formulas I and II are useful as agents in the prevention of allergic reactions.

  本文描述了具有以下结构的吡啶并[2,1-b]喹唑啉的化学式##STR1##其中R.sub.1、R.sub.1'、R.sub.2、R.sub.2'、R.sub.3、R.sub.3'、R.sub.4和R.sub.10如下所述，以及其制备方法。化合物I和II的化学式对于预防过敏反应是有用的。
• A Visible Light-Mediated Regioselective Halogenation of Anilides and Quinolines by Using a Heterogeneous Cu-MnO Catalyst
  作者：Harshvardhan Singh、Chiranjit Sen、Tapan Sahoo、Subhash Chandra Ghosh

  DOI：10.1002/ejoc.201801097

  日期：2018.9.16

  regioselective halogenation of anilides and quinolines with heterogeneous Cu‐MnO catalyst and under irradiation with a household 40 W incandescent lamp was developed. The catalyst is recyclable, acetonitrile as an industrially friendly solvent, and economic N‐halo succinimides as a halogenating source. The reaction is scalable and well tolerated with a broad range of functional groups.

  开发了一种简单实用的方法，用于使用多相Cu-MnO催化剂并在家用40 W白炽灯的照射下，对苯胺和喹啉进行区域选择性卤化。该催化剂是可回收的，乙腈为工业上友好的溶剂，经济的N卤代琥珀酰亚胺为卤化源。该反应是可扩展的并且具有广泛范围的官能团的良好耐受性。
• Site-Specific Synthesis of Carbazole Derivatives through Aryl Homocoupling and Amination
  作者：Jaeyoung Ban、Minkyung Lim、Saira Shabbir、Junghyun Baek、Hakjune Rhee

  DOI：10.1055/s-0039-1690759

  日期：2020.3

  We synthesized various carbazoles from anilines through a three-step process with good overall yields (up to 48%). This process comprises N-acetylation, copper(0)-mediated Ullmann homocoupling, and acid-mediated intramolecular amination. It permits various functional­ groups on the substrate. Scale-up of the developed three-step synthetic route to carbazoles was also demonstrated.

  我们通过三步法从苯胺合成了各种咔唑，总收率良好（高达48％）。该过程包括N-乙酰化，铜（0）介导的乌尔曼均偶联和酸介导的分子内胺化。它允许在基材上形成各种官能团。还证实了已开发的三步合成路线逐步扩大为咔唑。
• The Role of Ate Complexes in the Lithium-Sulfur, Lithium-Selenium and Lithium-Tellurium Exchange Reactions
  作者：Hans J. Reich、Birgir Ö. Gudmundsson、D. Patrick Green、Martin J. Bevan、Ieva L. Reich

  DOI：10.1002/1522-2675(200211)85:11<3748::aid-hlca3748>3.0.co;2-0

  日期：2002.11

  favor the T-shaped geometry of the hypervalent intermediates. For the selenium systems, ate complex intermediates (20-Se, 26) were detected spectroscopically in THF- or THF/HMPA-containing solutions. A DNMR study showed that Li/Se exchange was substantially faster than exchange of the lithium reagents with the ate complex. Therefore, these ate complexes are not on the actual Li/Se exchange pathway.

  高价配合物是金属-卤素、金属-碲和相关交换反应中的假定中间体。通过动力学技术和 NMR 光谱研究了 o,o'-联苯二基与二苯取代对碲酸盐络合物形成的影响。仅测量了关联常数 (Kate) 的适度增加。当通过间三联苯骨架 (12-S, 12-Se, 21) 在分子内实现 o,o'-联苯二硫化物和硒化物的 Li/M 交换时，Li/M 的速率大幅增加 (>109)与非循环模型相比，观察到 S 和 Li/Se 交换。显然，这些系统被理想地预先组织成有利于高价中间体的 T 形几何形状。对于硒系统，吃了复杂的中间体（20-Se，26) 在含有 THF 或 THF/HMPA 的溶液中进行光谱检测。DNMR 研究表明，Li/Se 交换比锂试剂与 at​​e 配合物的交换要快得多。因此，这些 ate 配合物不在实际的 Li/Se 交换途径上。
• [EN] ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATOR COMPOUNDS AS CANCER THERAPEUTICS<br/>[FR] COMPOSÉS ACTIVATEURS DU RÉCEPTEUR D'ARYL HYDROCARBONE (AHR) EN TANT QU'AGENTS THÉRAPEUTIQUES CONTRE LE CANCER
  申请人：BROAD INST INC

  公开号：WO2020102506A1

  公开（公告）日：2020-05-22

  The present disclosure relates to compositions and methods for the diagnosis and treatment or prevention of cancers, particularly cancers that exhibit elevated expression of FOXA1 and/or FOXA1 gene targets, such as certain breast, liver and/or prostate cancers, including luminal and/or ER-positive forms of breast cancer. Three previously identified adenosine receptor antagonists, CGS-15943, MRS-1220 and SCH-58261, as well as furan ring moiety-possessing derivatives of CGS-15943 are specifically provided for killing cancer cells in a manner that appears to involve activation of the aryl hydrocarbon receptor (AHR) by such compounds. The instant disclosure therefore provides for selecting and/or administering CGS-15943, MRS-1220, SCH-58261 and/or a furan-possessing derivative of CGS-15943, MRS-1220 and/or SCH-58261 as a therapeutic agent to target a cancer cell and/or subject having or at risk of developing a cancer. Methods and compositions for therapies that include such compounds are also provided

  本公开涉及与诊断和治疗或预防癌症有关的组合物和方法，特别是涉及表达FOXA1和/或FOXA1基因靶点升高的癌症，例如某些乳腺癌、肝癌和/或前列腺癌，包括乳腺癌的分泌性和/或ER阳性形式。已经确定的三种腺苷受体拮抗剂，CGS-15943、MRS-1220和SCH-58261，以及CGS-15943的呋喃环基团衍生物，专门用于以似乎涉及通过这些化合物激活芳香烃受体（AHR）来杀灭癌细胞。因此，本公开提供选择和/或施用CGS-15943、MRS-1220、SCH-58261和/或CGS-15943的呋喃基团衍生物，MRS-1220和/或SCH-58261作为靶向癌细胞和/或患有或有发展癌症风险的受试者的治疗剂的方法。还提供了包括这些化合物的治疗方法和组合物。